文献速递咽喉与嗓音

咳嗽抑制治疗对嗓音障碍严重程度的影响

Effects of Cough Suppression Therapy on Voice Disorder Severity.
PubMed 文献 · Laryngoscope · 2021-06-24

结果显示两组咳嗽严重程度均显著改善,咳嗽-嗓音组嗓音严重程度也显著改善,而咳嗽组VHI-10评分无显著变化。治疗次数中位数为3次(范围1-13次),严重程度变化与治疗次数无显著相关性。

要点

  • 咳嗽抑制治疗可显著改善慢性难治性咳嗽患者的咳嗽严重程度。
  • 对合并嗓音障碍的患者,咳嗽抑制治疗可同时改善嗓音严重程度。
  • 无嗓音障碍的慢性咳嗽患者,其VHI-10评分在治疗后无显著变化。

核心结论

  • 咳嗽抑制治疗是慢性难治性咳嗽合并嗓音障碍的统一治疗方法。
  • 针对主要症状慢性咳嗽的治疗可对嗓音产生交叉效应,改善共享通路系统的功能。

研究设计与样本

  • 按VHI-10评分严重程度分为咳嗽组27例和咳嗽-嗓音组16例。
  • 所有患者接受言语治疗师实施的咳嗽抑制治疗,并在治疗前后完成诊断检查和VHI-10及咳嗽严重程度指数评估。

主要发现

  • 治疗后两组咳嗽严重程度均显著改善。
  • 咳嗽-嗓音组嗓音严重程度显著改善。
  • 咳嗽组VHI-10评分无显著变化。
  • 治疗次数中位数为3次,范围1-13次。
  • 严重程度变化与治疗次数在检验水平上无显著相关性。

关键数值与推荐

  • 咳嗽-嗓音组根据VHI-10评分严重程度划分。
  • 治疗次数中位数为3次,范围1-13次。

临床怎么用

  • 对慢性难治性咳嗽合并嗓音障碍的患者,可考虑采用咳嗽抑制治疗以同时改善咳嗽和嗓音。
  • 治疗主要针对慢性咳嗽这一主要症状,嗓音功能可能随之获益。

局限性

  • 回顾性分析设计,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES//HYPOTHESIS: To determine changes in voice severity when treating chronic cough refractory to medical treatment with cough suppression therapy (CST) in patients with chronic cough and voice complaints. Chronic cough has been reported to be refractory to medical treatment and frequently co-occurs with voice disorders. The possible effects of CST on self-assessed changes in chronic cough and voice disorders have not been demonstrated. STUDY DESIGN: Retrospective analysis of the effects of cough suppression therapy (CST) on self-assessed changes in chronic cough and voice disorder severity in patients with both chronic cough and voice disorders. METHODS: Forty-three adult patients with the primary complaint of chronic refractory cough underwent pre- and post-treatment diagnostic examinations, completed pre- and post-treatment Voice Handicap Index-10 (VHI-10) and Cough Severity Index assessments, and were treated by a licensed speech-language pathologist using CST. Twenty-seven subjects were assigned to the cough (C) group and 16 to the cough-voice (CV) group based on the severity of their VHI-10 scores. RESULTS: Post-test analysis showed significant improvement in cough severity for both groups and significant improvement in voice severity for the CV group. The VHI-10 scores for the C group did not change significantly. The median number of treatment sessions was 3, with a range of 1-13 sessions. Correlation between changes in severity and number of treatment sessions was not found to be significant at the tested level. CONCLUSIONS: CST represents a unifying approach for treatment of patients with CRC and comorbid voice disorders. CST offered cross-over effects to the voice when subjects were treated for their primary complaint of chronic cough. This treatment of the primary complaint improves function in systems that share a common pathway. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:2747-2751, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. LaTour D, Crawley B, Krishna P, et al. Effects of Cough Suppression Therapy on Voice Disorder Severity. Laryngoscope. 2021. PMID: 34165792. doi:10.1002/lary.29705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。